Development of an EKA application to help tuberculosis patients improve medication adherence and self efficacy

Lie Liana Fuadiati, Tintin Sukartini, Makhfudli Makhfudli, Yulis Setiya Dewi, Alfian Nur Rosyid, Arina Qona’ah


Tuberculosis treatment is carried out daily for a long time, causing boredom with taking medication and reducing medication adherence. It results in drug resistance and more prolonged treatment. In response to the situation, this study developed an android-based application called the education, calendar, and medication alarm (EKA) app to improve medication adherence and self-efficacy of tuberculosis patients. Research and development with four steps: evaluation of health education, medication adherence, and self-efficacy; application development; feasibility test; and application socialization. The sample in this study was 38 respondents. This study also uses morisky medication adherence scale (MMAS-8), self-efficacy, and system usability scale (SUS) questionnaires and evaluation sheets to collect the data. Data analysis was done descriptively. The outcomes of the application feasibility test showed that the EKA application received an acceptable value of 81.5 based on acceptance, B value (81.5) based on value scale, an excellent value (81.5) based on adjective rating, and good score (81.5) based on percentile. Socialization on the use of the application goes well, and the patient gets a good understanding and can use the EKA application easily. It proves that the android-based EKA application tested using the SUS questionnaire can be used as a medium for health education and supports medication adherence and self-efficacy.

Full Text:




  • There are currently no refbacks.

International Journal of Public Health Science (IJPHS)
p-ISSN: 2252-8806, e-ISSN: 2620-4126

This journal is published by the Intelektual Pustaka Media Utama (IPMU) in collaboration with Institute of Advanced Engineering and Science (IAES).

View IJPHS Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.